ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Infectious diseases · Vaccine · 2026-10-09

Qualitative secondary analysis of the Add-Vacc cluster-randomised trial offering single-dose HPV vaccine to males aged 14–18 in northwest Tanzania: shifting COVID-19 policies fed mistrust and rumours (a concealed COVID-19 vaccine, depopulation, fertility) affecting acceptance.

Secondary analysis
Malibwa et al. Influence of COVID-19 and COVID-19 rumours on trust and uptake of single-dose male HPV vaccination in the Add-Vacc cluster-randomised trial, northwest Tanzania
Infectious diseases · Vaccine · 2025-12-17

Mixed-methods process evaluation (secondary analysis) of the PrevHPV cluster RCT: of 31 schools randomised to at-school HPV vaccination, 12 (39%) dropped out; in participating schools 17% of adolescents returned valid consent, 89% of whom started vaccination.

Secondary analysisn = 31 schools
Bocquier et al. Process evaluation of a school-based vaccination intervention to improve HPV vaccine coverage: A mixed-method study embedded in the French PrevHPV cluster randomized controlled trial

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.